Cytokinetics (NASDAQ:CYTK) Posts Quarterly Earnings Results, Misses Estimates By $0.02 EPS
Cytokinetics (NASDAQ:CYTK – Get Free Report) announced its earnings results on Tuesday. The biopharmaceutical company reported ($1.50) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.48) by ($0.02), Zacks reports. Cytokinetics Stock Performance Shares of Cytokinetics stock traded up $1.84 during trading on Tuesday, reaching $70.10. 1,938,392 shares of the company’s stock […]
24 Feb 22:00 · The Markets Daily